Body

Thrombosis patients face greater risks than previously believed

Plants display 'molecular amnesia'

Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics. They have demonstrated for the first time the reversal of what is called epigenetic silencing in plants.

Old as you want to be: Study finds most seniors feel younger

ANN ARBOR, Mich.---Older people tend to feel about 13 years younger than their chronological age.

That is one of the findings of a study forthcoming in the Journals of Gerontology: Psychological Science. The researchers analyzed the responses of 516 men and women age 70 and older who participated in the Berlin Aging Study, tracking how their perceptions about age and their satisfaction with aging changed over a six-year period.

Is empty nest best? Changes in marital satisfaction in late middle age

The phrase "empty nest" can conjure up images of sad and lonely parents sitting at home, twiddling their thumbs, waiting for their children to call or visit. However, a new study, reported in Psychological Science, a journal of the Association for Psychological Science, suggests that an empty nest may have beneficial effects on the parents' marriage.

Concordia University researcher develops image processing system that detects moods

MONTREAL, CANADA/ December 2, 2008 – Who knows what evil lurks in the hearts of men? Dr. Prabir Bhattacharya and his computers might. He and Concordia graduate student Abu Sayeed Sohail are developing a computer image processing system that detects and classifies human facial expressions.

New holographic method could be used for lab-on-a-chip technologies

WEST LAFAYETTE, Ind. - Researchers at Purdue University have developed a technique that uses a laser and holograms to precisely position numerous tiny particles within seconds, representing a potential new tool to analyze biological samples or create devices using nanoassembly.

The technique, called rapid electrokinetic patterning, is a potential alternative to existing technologies because the patterns can be more quickly and easily changed, said mechanical engineering doctoral student Stuart J. Williams.

Gene which protects against lung cancer identified

A study led by researchers at The University of Nottingham has identified a gene that protects the body from lung cancer.

The research, published in the journal Proceedings of the National Academy of Sciences, USA and funded by a £72,000 grant from the British Lung Foundation, has found that the tumour suppressor gene, LIMD1, is responsible for protecting the body from developing lung cancer — paving the way for possible new treatments and early screening techniques.

Drop in cancer deaths tied primarily to gains in behavior and screening

CAMBRIDGE, Mass., Dec. 2, 2008 – Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.

Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints

Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints. HZT 501, a novel, proprietary fixed-dose combination product containing ibuprofen and famotidine, demonstrated a statistically significant reduction in the incidence of non-steroidal anti-inflammatory drug (NSAID)-induced upper gastrointestinal (gastric and/or duodenal) ulcers in patients with mild-to-moderate pain when compared to ibuprofen alone.

HER2 levels may aid in treatment selection for metastatic breast cancer

PHILADELPHIA – Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. In addition, a misclassification of metastatic breast cancer patients by as much as 10 percent prevents some people from receiving optimal therapy.

Cold Spring Harbor Protocols features tissue culture methods for immune cells and neurons

COLD SPRING HARBOR, N.Y. (Tues., Dec. 2, 2008) – The complexity of vital organ systems makes them difficult to study in living organisms. Tissue culture methods for specific cell types allow researchers to break these systems down into component parts that can be readily manipulated and observed.

AASM responds to the Institute of Medicine's report on fatigue and medical resident hours

WESTCHESTER, Ill. – The American Academy of Sleep Medicine (AASM) commends the Institute of Medicine of the National Academies (IOM) for its independent analysis of current duty-hour regulations for medical residents. The AASM will conduct a thorough review of the recommendations made in today's IOM report, "Resident Duty Hours: Enhancing Sleep, Supervision, and Safety."

Elsevier announces the 2008 supplement of Reproductive Health Matters

Amsterdam, 2 December 2008 - Elsevier announced today the publication of Reproductive Health Matters 2008 Supplement on the theme of "Second trimester abortion: women's health and public policy". Second trimester abortion raises complex issues regarding methods, values, stigma, the burden on providers of service delivery and the sometimes complicated reality of women's lives and decisions.

Toys made of liquid wood

Toys have to put up with a lot of rough treatment: They are sucked by small children, bitten with milk teeth, dragged along behind bobby cars, and every now and then they have to survive a rainy night outdoors. Whatever happens, it is vital that the material does not release any softeners or heavy metals that could endanger children.

Risk of death may be higher with drug commonly used during cardiac surgery

The risks of death are probably higher with aprotinin, a drug commonly used to control blood loss and transfusions during cardiac surgery, compared with lysine analogues, according to a study http://www.cmaj.ca//cgi/rapidpdf/cmaj.081109 to be published in the January 20th issue of CMAJ.

On December 3, a Health Canada expert advisory panel will meet to decide on aprotinin use. The study is being early released in advance of the meeting.